Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany UpdateResults6 Aug 2026

Citadel Realty and Developers Ltd

Newspaper Publication of Un-Audited Financial Results for Quarter ended June 30, 2026.

Citadel Realty and Developers Ltd has published its un-audited financial results for the quarter ended June 30, 2026, in compliance with Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results show a total income from operations of ₹2,855.22 lakhs and a net profit for the period before tax of ₹181.13 lakhs.

Read more →📎 1 attachment
BSECorp. ActionResults6 Aug 2026

JK Paper Ltd

Intimation of Book Closure

JK Paper Ltd has announced the book closure for its 65th Annual General Meeting (AGM) to be held on September 2, 2026. The register of members and share transfer books will be closed from August 20 to September 2, 2026. The company will pay a dividend of Rs. 4 per share (40% of the face value) to members whose names are borne on the register on August 19, 2026.

Read more →📎 1 attachment
NSEUpdates▲ PositiveResults6 Aug 2026

Edelweiss Financial Services Limited

Updates

Edelweiss Financial Services Limited has announced its earnings update for the first quarter ended June 30, 2026, with a consolidated PAT of INR 122 Cr, a 83% YoY growth. The company's alternative asset management fee-paying AUM grew by 27% YoY to INR 48,623 Cr, and mutual fund equity AUM increased by 32% YoY to INR 96,000 Cr. The company's total customer reach increased to 14 Mn, up 30% YoY, and customer assets at INR 2.8 Tn, up 23% YoY.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults6 Aug 2026

Zim Laboratories Limited

Outcome of Board Meeting

Zim Laboratories Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, which includes revenue from operations of Rs. 9,417.85 lakhs and total income of Rs. 9,517.08 lakhs. The company's expenses include cost of materials consumed of Rs. 4,381.61 lakhs and total expenses of Rs. 5,432.52 lakhs. The results are subject to a limited review by Deloitte Haskins & Sells LLP.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults6 Aug 2026

Emcure Pharmaceuticals Limited

Investor Presentation

Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation, which includes unaudited financial results for Q1FY27. The presentation highlights a strong all-round performance with increased revenue and growth in the International business (58% contribution). Domestic revenue growth is at 10.2%, with productivity gains and operating leverage improving EBITDA margin by 50 bps and PAT margin by 110 bps. The company has also announced key appointments and restructuring of its leadership and operations.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults6 Aug 2026

Edelweiss Financial Services Ltd

Earnings Update

Edelweiss Financial Services Ltd has announced its earnings update for the quarter ended June 30, 2026, showing a 83% YoY growth in consolidated PAT to INR 122 Cr, with robust growth in alternative asset management fee-paying AUM and mutual fund equity AUM.

Read more →📎 1 attachment
BSECompany UpdateResults6 Aug 2026

Kamat Hotels (India) Ltd

Intimation of Q1-FY2027 Earnings Conference Call of Kamat Hotels (India) Limited

Kamat Hotels (India) Ltd has announced its Q1-FY2027 Earnings Conference Call, to be held on August 12, 2026, at 12:00 Noon (IST). The call will discuss the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The management will be represented by Mr. Vishal Vithal Kamat, Mr. Milind Wadekar, and Mr. Nikhil Singh.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults6 Aug 2026

Trent Limited

Press Release

Trent Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue growth of 19% and operating profit growth of 36%.

Read more →📎 1 attachment
BSEResultResults6 Aug 2026

Emcure Pharmaceuticals Ltd

Unaudited Financial Results (Standalone and consolidated) for the quarter ended June 30, 2026

Emcure Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results at its meeting held on August 6, 2026. The company has enclosed the unaudited financial results and a limited review report by its statutory auditors, B S R & Co. LLP, with the announcement.

Read more →📎 1 attachment
BSEBoard MeetingResults6 Aug 2026

Asia Capital Ltd

Financial Result for the Quarter Ended June 30, 2026

Asia Capital Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors considering and approving the results along with the Limited Review Report issued by Statutory Auditors. The company has also appointed a Secretarial Auditor and Internal Auditor for the financial year 2025-2026.

Read more →📎 1 attachment
← PreviousPage 1082 of 2047Next →